课题基金 / 基金详情

ROLE OF CTLA 4 IN IMMUNE TOLERANCE IN HUMANS

ROLE OF CTLA 4 IN IMMUNE TOLERANCE IN HUMANS
CTLA 4 在人类免疫耐受中的作用
批准号:
6266272
负责人:
EDGAR G. ENGLEMAN
金额:
$26.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2004-02-28

项目摘要

项目成果

EDGAR G. ENGLEMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract) CTLA-4, a transmembrane protein expressed transiently on activated T cells, downregulates T cell activation and promotes tolerance in experimental animals. However, neither the molecular basis for these effects nor the extent to which CTLA-4 influences the human immune system are known. Our preliminary findings indicate that CTLA-4 triggering blocks cell cycle progression and promotes anergy in human CD4+ T cells, in vitro. The goals of this project are to define the molecular basis for these effects and determine if CTLA-4 plays a role in regulating human T cell responses, in vivo. Four specific aims are proposed: 1) to determine the function of CTLA-4 in the induction and maintenance of anergy in adult human T cells; 2) to define the molecular basis for CTLA-4 signalling by introducing into human T cells selected mutant forms of CTLA-4 and a variety of signalling intermediates; 3) to determine the role of CTLA-4 in regulating the immune response to self and non-self antigens, in vivo, in immunocompetent SCID/Hu mice; and 4) to determine if administration of anti-CTLA-4 antibody can reverse tolerance to a tumor associated antigen, in vivo, under conditions that mimic those in human cancer. The results of these studies should not only allow us to determine if and how CTLA-4 affects tolerance induction and maintenance in humans but potentially provide the basis for an effective immunotherapeutic approach to cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1 Mouse Models Analysis
  • 批准号:
    10729466
  • 项目类别:
  • 资助金额:
    $56.36万
  • 财政年份:
    2023
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression
  • 批准号:
    10729464
  • 项目类别:
  • 资助金额:
    $191.91万
  • 财政年份:
    2023
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
  • 批准号:
    10704089
  • 项目类别:
  • 资助金额:
    $42.16万
  • 财政年份:
    2021
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
Targeting Lymph Node Dependent Immune Tolerance in Cancer
  • 批准号:
    10210557
  • 项目类别:
  • 资助金额:
    $53.17万
  • 财政年份:
    2021
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
海外基金